FDA.reportPublic FDA data

doxylamine / pyridoxine Extended Release Oral Tablet [Bonjesta]

RxCUI
1999654
RxNorm name
doxylamine / pyridoxine Extended Release Oral Tablet [Bonjesta]
Term type
SBDF
Status
Active
Updated
2026-11-06 11:39:51

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
032018
Active start
032018
Multiple ingredient
YES
Branded
YES

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Extended Release Oral Tablet316945

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
doxylamine3642
pyridoxine684879

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
PRESCRIBABLEY1ATTRIBUTES
RXNAV_STRdoxylamine / pyridoxine Extended Release Oral Tablet [Bonjesta]1NAMES
RxNorm Namedoxylamine / pyridoxine Extended Release Oral Tablet [Bonjesta]1NAMES
TTYSBDF1ATTRIBUTES
RxCUI19996541CODES

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 0 matching rows.

No records found.

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCR06AAAminoalkyl ethersATC1-4doxylamine
ATCA11HAOther plain vitamin preparationsATC1-4pyridoxine
FDASPLD025101Vitamin B 6CHEMhas_chemical_structurepyridoxine
FDASPLN0000175750AntihistamineEPChas_epcdoxylamine
FDASPLN0000192800Vitamin B6 AnalogEPChas_epcpyridoxine
FDASPLN0000000207Histamine Receptor AntagonistsMOAhas_moadoxylamine
MEDRTD004319DoxylamineCHEMhas_ingredientdoxylamine
MEDRTD004319DoxylamineCHEMhas_ingredientdoxylamine succinate
MEDRTD011736PyridoxineCHEMhas_ingredientpyridoxine hydrochloride
MEDRTD011736PyridoxineCHEMhas_ingredientpyridoxine
MEDRTD004342Drug HypersensitivityDISEASEci_withpyridoxine hydrochloride
MEDRTD004342Drug HypersensitivityDISEASEci_withpyridoxine
MEDRTD004342Drug HypersensitivityDISEASEci_withdoxylamine succinate
MEDRTD004342Drug HypersensitivityDISEASEci_withdoxylamine
MEDRTD064420Drug-Related Side Effects and Adverse ReactionsDISEASEmay_treatpyridoxine hydrochloride
MEDRTD064420Drug-Related Side Effects and Adverse ReactionsDISEASEmay_treatpyridoxine
MEDRTD064420Drug-Related Side Effects and Adverse ReactionsDISEASEmay_preventpyridoxine
MEDRTD064420Drug-Related Side Effects and Adverse ReactionsDISEASEmay_preventpyridoxine hydrochloride
MEDRTD006261HeadacheDISEASEmay_treatdoxylamine
MEDRTD006261HeadacheDISEASEmay_treatdoxylamine succinate
MEDRTD012221Rhinitis, Allergic, PerennialDISEASEmay_treatdoxylamine
MEDRTD012221Rhinitis, Allergic, PerennialDISEASEmay_treatdoxylamine succinate
MEDRTD012640SeizuresDISEASEmay_treatpyridoxine hydrochloride
MEDRTD012640SeizuresDISEASEmay_treatpyridoxine
MEDRTD007319Sleep Initiation and Maintenance DisordersDISEASEmay_treatdoxylamine
MEDRTD007319Sleep Initiation and Maintenance DisordersDISEASEmay_treatdoxylamine succinate
MEDRTD026681Vitamin B 6 DeficiencyDISEASEmay_treatpyridoxine hydrochloride
MEDRTD026681Vitamin B 6 DeficiencyDISEASEmay_preventpyridoxine hydrochloride
MEDRTD026681Vitamin B 6 DeficiencyDISEASEmay_preventpyridoxine
MEDRTD026681Vitamin B 6 DeficiencyDISEASEmay_treatpyridoxine
MEDRTN0000000163Enzyme InteractionsMOAhas_moapyridoxine hydrochloride
MEDRTN0000000163Enzyme InteractionsMOAhas_moapyridoxine
MEDRTN0000000190Histamine H1 Receptor AntagonistsMOAhas_moadoxylamine succinate
MEDRTN0000000190Histamine H1 Receptor AntagonistsMOAhas_moadoxylamine
MEDRTN0000008337Cellular Activity AlterationPEhas_pepyridoxine hydrochloride
MEDRTN0000008337Cellular Activity AlterationPEhas_pepyridoxine
MEDRTN0000008657Decreased Histamine ActivityPEhas_pedoxylamine succinate
MEDRTN0000008657Decreased Histamine ActivityPEhas_pedoxylamine

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESRXNAV_HUMAN_DRUGUS